当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 资产负债表

华北制药

(600812)

  

流通市值:89.56亿  总市值:89.56亿
流通股本:17.16亿   总股本:17.16亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金1,384,871,890.281,541,414,202.121,605,062,335.691,600,060,681.55
  应收票据及应收账款2,604,085,233.42,411,368,822.432,422,540,197.372,589,421,441.65
        应收账款2,604,085,233.42,411,368,822.432,422,540,197.372,589,421,441.65
  应收款项融资259,054,539.81183,670,124.47350,394,389.11327,752,319.64
  预付款项107,247,114.9393,989,453.56207,259,110.33208,749,746.79
  其他应收款合计1,395,477,329.931,382,129,629.941,407,547,938.61,408,009,946.29
  其中:应收利息175,000175,000-1,788,686.87
  存货2,413,363,684.092,410,852,410.362,253,265,923.692,317,336,084.07
  其他流动资产101,250,614.78107,871,454.590,550,497.32113,060,321.76
  流动资产合计8,265,350,407.228,131,296,097.388,336,620,392.118,564,390,541.75
非流动资产:
  长期股权投资1,261,742,427.131,247,085,553.171,228,642,491.571,213,108,199.94
  其他权益工具投资5,035,0005,035,00017,700,00017,700,000
  固定资产6,223,254,1286,362,233,837.346,256,511,256.96,236,049,711.39
  在建工程269,048,271.09259,600,989.02378,116,789.56464,256,514.65
  使用权资产248,024,031.25257,803,948.97331,771,339.51343,790,959.52
  无形资产2,987,910,610.223,024,497,212.092,846,843,592.122,753,105,908.53
  开发支出2,073,185,197.611,986,986,026.042,009,743,438.682,026,429,028.83
  长期待摊费用67,571,620.8468,214,510.2258,901,559.4961,677,111.69
  递延所得税资产50,889,164.7449,150,212.7372,434,064.6272,434,064.62
  非流动资产合计13,186,660,450.8813,260,607,289.5813,200,664,532.4513,188,551,499.17
  资产总计21,452,010,858.121,391,903,386.9621,537,284,924.5621,752,942,040.92
流动负债:
  短期借款6,366,431,515.286,242,124,372.076,619,707,942.876,857,862,213.27
  应付票据及应付账款2,429,543,702.572,451,020,041.532,198,867,569.752,635,300,043.16
  其中:应付票据448,512,698.42476,610,979.31391,107,979.2640,805,000
        应付账款1,981,031,004.151,974,409,062.221,807,759,590.551,994,495,043.16
  合同负债164,984,118.37161,481,735.16167,621,266.19191,331,762.23
  应付职工薪酬189,619,334.02183,604,195.52194,880,533.46191,682,510.37
  应交税费63,324,823.160,266,659.3555,729,751.7445,412,176.53
  其他应付款合计308,268,168.92310,697,076.33468,003,915.97436,218,827.75
  其中:应付利息2,170,999.66771,055.8611,151,367.3719,057.5
        应付股利385,687.5385,687.5385,687.553,355,931.93
  一年内到期的非流动负债1,894,024,627.912,971,999,114.52,185,396,153.031,223,710,309.92
  其他流动负债20,470,238.7918,071,190.23519,466,289.37527,200,227.33
  流动负债合计11,436,666,528.9612,399,264,384.6912,409,673,422.3812,108,718,070.56
非流动负债:
  长期借款2,351,818,0001,376,674,659.722,181,118,0002,660,139,000
  应付债券500,000,000500,000,000--
  租赁负债124,529,982.74124,434,082.95149,772,417.7147,601,874.02
  长期应付款16,180,00016,180,0008,317,0009,735,000
  递延收益88,373,585.8289,802,253.5785,271,762.1573,391,910.74
  递延所得税负债551,027.44551,027.4429,103,732.4329,103,732.43
  非流动负债合计3,081,452,5962,107,642,023.682,453,582,912.282,919,971,517.19
  负债合计14,518,119,124.9614,506,906,408.3714,863,256,334.6615,028,689,587.75
所有者权益(或股东权益):
  实收资本(或股本)1,715,730,3701,715,730,3701,715,730,3701,715,730,370
  资本公积3,869,810,132.553,869,792,329.163,869,803,463.593,867,181,951.08
  其他综合收益-7,974,360.77-6,312,061.397,725,829.767,523,192.61
  专项储备1,969,228.75806,861.41,703,679.81,392,737.62
  盈余公积339,420,156.84339,420,156.84333,357,636.58333,357,636.58
  未分配利润-369,133,555.76-404,606,383.25-423,096,005.08-458,102,620.94
  归属于母公司股东权益合计5,549,821,971.615,514,831,272.765,505,224,974.655,467,083,266.95
  少数股东权益1,384,069,761.531,370,165,705.831,168,803,615.251,257,169,186.22
  股东权益合计6,933,891,733.146,884,996,978.596,674,028,589.96,724,252,453.17
  负债和股东权益合计21,452,010,858.121,391,903,386.9621,537,284,924.5621,752,942,040.92
公告日期2026-04-252026-04-182025-10-252025-08-14
审计意见(境内)标准无保留意见
TOP↑